Management of Asthma

• Knowledge Translation in Health Care: from evidence to practice
• Emergency Approach to Asthma Attacks in adults & children
• Fixed airflow obstruction in Asthma: pathological basis and consequences for treatment
• The role of infection in Asthma exacerbations
• Occupational Asthma
• Asthma and obesity: what is the relationship?
• Management of asthma in pregnancy
• Endotyping Asthma
• Airways Remodeling and Pulmonary Function Decline
• Modulation of Airways Remodeling as Target of Treatment
• Asthma Awareness at first step of right management
• Modern Technologies to implement Asthma Management
• Different Treatment Strategies for Asthma Control
• Asthma: a disease of many phenotypes
• Asthma in the elderly

Asthma & COPD

• The Path to Precision Medicine in COPD
• New COPD Treatments
• Tobacco smoking & Asthma
• Adherence to Treatment in Allergy, Asthma & COPD: a neglected issue
• Smoking Cessation – Essential part of asthma treatment
• The Path to Personalized Medicine in Asthma
• Patient Stratification and proper Treatment

Enviroment & Asthma

• Climate Change & Allergic Asthma
• Biodiversity and allergic disease
• The added value of CRD-Component Resolved Diagnosis in Respiratory Allergy
• Probiotics and Asthma
• The changing microbiome and allergy
• OMICS: a step forward in understanding Asthma

New Treatments on Asthma

• AIT-Allergen ImmunoTherapy in Asthma: emerging evidences
• Monoclonal antibodies on Asthma Treatment
• Biomarkers of treatment responses
• Thermoplasty and Asthma Treatment: new evidences

Primary Health Care and Asthma

• Basic principles of guidelines implementation
• Translation of GINA strategy into care
• How to address care gaps in primary care
• A Novel paradigm for generating relevant evidence for guidelines: real life trials
• COPD Treatments as future Asthma Treatment
• Integrated Care Pathways in Obstructive Bronchial Diseases
• Inhaled corticosteroids: different mechanisms and efficacy in Asthma and COPD

Severe Asthma

• Genetic factors and epigenetics
• Pharmacogenetics in deciding treatment options
• How does epithelial integrity protect against environmental insults
• Severe Asthma: a different phenotype or different phenotypes?
• New biologic agents for treating severe Asthma
• Clusters and biomarkers of severe asthma in adults
• LAMA in Asthma: only for patients with severe poorly reversible airflow obstruction?

Upper airways and Asthma

• Breakdown in epithelial protection in Rhinosinusitis
• Links between asthma and rhinitis
• Upper airway influences on lower airways
• Chronic rhinosinusitis and asthma in childhood
• Predictive risk of rhinitis for asthma in children
• Severe Paediatric asthma